BCIQ Profiles

Company Profile Report

Takeda divests stake in Chinese JV Techpool

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on May 23 that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China)

Read the full 311 word article

How to gain access

Continue reading with a
two-week free trial.